Albumin-bound Paclitaxel (ABI-007) for Patients With Advanced Non-Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT00540514. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Phase III Trial of ABI-007 and Carboplatin Compared With Taxol and Carboplatin as First-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare disease response of Albumin-bound paclitaxel (ABI-007) plus Carboplatin versus Taxol and Carboplatin as first-line therapy in patients with advanced non-small cell lung cancer (NSCLC).
Study identification
- NCT ID
- NCT00540514
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,052 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 1, 2007 (Actual)
- Primary completion
- Oct 1, 2009 (Actual)
- Completion
- Feb 1, 2013 (Actual)
- Last update posted
- Oct 29, 2019
2007 – 2013
United States locations
- U.S. sites
- 31
- U.S. states
- 18
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clearview Cancer Institute Oncology Specialties, P.C. | Huntsville | Alabama | 35805 | — |
| Genesis Cancer Center- Hot Springs | Hot Springs | Arkansas | 71913 | — |
| Little Rock Hematology Oncology Associates | Little Rock | Arkansas | 72205 | — |
| Pacific Cancer Medical Center, Inc. | Anaheim | California | 92801 | — |
| Comprehensive Blood and Cancer Center | Bakersfield | California | 93309 | — |
| Southwest Cancer Care | Escondido | California | 92064 | — |
| Robert A. Moss, MD, FACP, Inc. | Fountain Valley | California | 92708 | — |
| Pacific Shores Medical Group | Long Beach | California | 90813 | — |
| Ventura County Hematology-Oncology Specialists | Oxnard | California | 93030 | — |
| Comprehensice Cancer Ctr. | Palms Springs | California | 92262 | — |
| Gulf Coast Oncology Associates | St. Petersburg | Florida | 33705 | — |
| Lake County Oncology and Hematology, PA | Tavares | Florida | 32778 | — |
| Phoebe Cancer Center | Albany | Georgia | 31701 | — |
| Cancer Center of Kansas | Wichita | Kansas | 67214 | — |
| Kentuckiana Cancer Institute, PLLC | Louisville | Kentucky | 40202 | — |
| Mercy Hospital | Portland | Maine | 04101 | — |
| Maine Center for Cancer Medicine | Scarborough | Maine | 04074 | — |
| Mercy Medical Center | Baltimore | Maryland | 21202 | — |
| St. Louis University | St Louis | Missouri | 63110 | — |
| Essex Oncology of North Jersey | Belleville | New Jersey | 07109 | — |
| Mary Imogene Bassett Hospital | Cooperstown | New York | 13326 | — |
| University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599 | — |
| St. Mary Medical Center- Oncology, Hematology PC | Langhorne | Pennsylvania | 19047 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| Dallas Oncology Consultants, PA | Duncanville | Texas | 75137 | — |
| The Center for Cancers and Blood Disorders | Fort Worth | Texas | 76104 | — |
| Joe Arrington Cancer Research and Treatment Center | Lubbock | Texas | 79410 | — |
| Blood and Cancer Center of East Texas | Tyler | Texas | 75701 | — |
| Tyler Hematology Oncology | Tyler | Texas | 75701 | — |
| Fletcher Allen Health Care | Burlington | Vermont | 05405 | — |
| Cancer Outreach Associates, PC | Abingdon | Virginia | 24211 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00540514, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 29, 2019 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00540514 live on ClinicalTrials.gov.